ResearcherUniversity of California, San FranciscoNo recent work listed

Anna Moroz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5533-5700; OpenAlex author ID A5112570941. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2020: 1 paper

Papers 1

Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-20-0268 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jeremy M. Sharib · 1 shared paper, 2020 · strength 0.09
- Paper Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-20-0268 ↗
Michael J. Evans · 1 shared paper, 2020 · strength 0.09
- Paper Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-20-0268 ↗
Eric Andrew Collisson · 1 shared paper, 2020 · strength 0.09
- Paper Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-20-0268 ↗
Kimberly Saunders Kirkwood · 1 shared paper, 2020 · strength 0.09
- Paper Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-20-0268 ↗
James A Wells · 1 shared paper, 2020 · strength 0.09
- Paper Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-20-0268 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.